The Government of Kerala has green-lit a major life-sciences hub Genome City Kerala to be constructed at Bio360 Life Sciences Park in Thonnakkal, Thiruvananthapuram. The planned 60-acre campus is slated for a total investment of ₹ 3,500 crore and is designed to be a comprehensive cluster for biotech, pharmaceuticals, medical devices, and research institutions. 

The project is envisaged as an integrated ecosystem combining manufacturing, R&D, testing labs, quality control and export-ready facilities. Planners view Genome City as Kerala’s answer to established biotech hubs  aiming to attract both domestic and multinational companies. The strategic value lies in the site’s logistics advantage: easy access to Thiruvananthapuram’s international airport and the nearby Vizhinjam Seaport, which can facilitate import of raw materials and export of finished medical products and devices. 

Officials project that the hub will create about 15,000 direct jobs, while the indirect employment through ancillary services, supply-chain partners and logistics could be much higher.  To ease setup for investors, the government plans to offer facilities such as subsidized land leases, equipment subsidies, and fast-tracked clearances via a single-window portal signalling strong institutional support. broader push by Kerala to become a major player in life sciences, building on existing initiatives such as the Kerala Genome Data Centre (KGDC) and other biotech/medical-device projects under the state’s industrial innovation drive.